Res exerts neuroprotective effects against cerebral ischemia–reperfusion injury, potentially by modulating microglial polarization toward the M2 phenotype via the Epac-1/Rap-1 signaling pathway, thereby suppressing inflammation and mitigating neuronal damage. The gene discussed is RAPGEF3; the disease is brain ischemia.